The U.S. Supreme Court has denied the last of three petitions seeking review of a Pennsylvania ruling that thousands of generic Reglan users’ state court product liability claims weren... Read more
The firm recently announced a significant move in our Mass Torts Section. We have named four lawyers as new Principals in the firm. These lawyers are David Dearing, James Lampkin, Danielle W... Read more
A decision by the New Jersey Appellate Division has preserved patients’ claims that manufacturers of generic Reglan failed to adequately warn about neurological risks associated with R... Read more
The Alabama Supreme Court recently upheld its decision in Wyeth v. Weeks, holding that brand-name drug manufacturers can be held liable for injuries caused by their generic counterparts. The... Read more
Danielle Ward Mason, who joined Beasley Allen in 2009, works in the firm’s Mass Torts Section. Her work involves the investigating of claims relating to dangerous drugs and medical dev... Read more
The outcome of a most interesting case was reported last month involving Reglan claims. It was reported that Alaven Pharmaceutical LLC settled its claims that First Specialty Insurance Corp.... Read more
Reglan battles continue to wage on throughout the country on two fronts – generic Defendants continue to allege that federal law preempted them from strengthening their warning labels and br... Read more
Chad Cook, a lawyer in our Mass Torts Section, is currently responsible for a number of cases including Fosamax,Heparin, Reglan and Zithromax litigation. He also assists in investigating new... Read more
Plaintiffs involved in Reglan litigation won a big victory against brand name drug manufacturers Wyeth, Pfizer, and Schwarz Pharma, as the result of a very good decision recently decided by... Read more
Reglan battles continue to wage on throughout the country on two fronts – generic Defendants continue to allege that federal law preempted them from strengthening their warning labels, and b... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.